Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease-Reference-Cited by-同舟云学术

Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease

Published:2014-03-10 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Kew Kayleigh M¹,Seniukovich Alieksei²

Affiliation:

1. St George's, University of London; Population Health Research Institute; Cranmer Terrace London UK SW17 0RE

2. Grodno Clinic Hospital #2; 3, ul. Transportnaya Grodno Belarus PO Box 230020

Publisher

Wiley

Subject

Pharmacology (medical)

Reference252 articles.

1. Effect of fluticasone propionate/salmeterol (250/50) on COPD exacerbations and impact on patient outcomes;Anzueto;Journal of Chronic Obstructive Pulmonary Disease,2009

2. Dalal AA Blanchette CM Petersen H St. Charles M Cost-effectiveness of fluticasone propionate/salmeterol (250/50mcg) compared to salmeterol (50mcg) in patients with chronic obstructive pulmonary disease: economic evaluation of study SCO100250 [Abstract] American Thoracic Society International Conference; 2009 May 15-20; San Diego 2009 A1502 [Poster K54]

3. Which patients with chronic obstructive pulmonary disease benefit from the addition of an inhaled corticosteroid to their bronchodilator? A cluster analysis;DiSantostefano;BMJ Open,2013

4. GlaxoSmithKline A Randomized, Double-Blind, Parallel-Group, 52-Week Study to Compare the Effect of Fluticasone Propionate/Salmeterol DISKUS 250/50mcg BID with Salmeterol DISKUS 50mcg BID on the Annual Rate of Moderate/Severe Exacerbations in Subjects with Chronic Obstructive Pulmonary Disease (COPD). SCO100250 www.gsk-clinicalstudyregister.com/

5. GlaxoSmithKline A randomized, double-blind, parallel-group, 52-week study to compare the effect of fluticasone propionate/salmeterol DISKUS 250/50mcg bid with salmeterol DISKUS 50mcg bid on the annual rate of moderate/severe exacerbations in subjects with chronic obstructive pulmonary disease (COPD) www.gsk-clinicalstudyregister.com/

Cited by 332 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Einsatz von Dupilumab bei COPD mit eosinophiler Inflammation;Pneumo News;2024-09

2. Management of chronic obstructive pulmonary disease in Algeria and implementation of international recommendations;The Egyptian Journal of Chest Diseases and Tuberculosis;2024-07

3. Survival benefit of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: a nationwide cohort study;Scientific Reports;2024-06-26

4. Exploration of quantitative-effectiveness association between acupuncture temporal parameters and stable chronic obstructive pulmonary disease: A systematic review and dose-response meta-analysis of randomized controlled trials;Complementary Therapies in Medicine;2024-06

5. Accuracy of the recording of pneumonia events in English electronic healthcare record data in patients with chronic obstructive pulmonary disease;Pneumonia;2024-05-05